Compounds > thiazolidines
Page last updated: 2024-08-21

thiazolidines and Hyperglycemia, Postprandial

thiazolidines has been researched along with Hyperglycemia, Postprandial in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.11)18.2507
2000's2 (11.11)29.6817
2010's13 (72.22)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Aoki, S; Atsumi, T; Cho, KY; Kameda, H; Kawata, S; Kurihara, Y; Miya, A; Miyoshi, H; Nagai, S; Nakamura, A; Nishimoto, N; Nomoto, H; Omori, K; Shigesawa, I; Sugawara, H; Takeuchi, J; Taneda, S; Tsuchida, K; Yanagiya, S; Yokoyama, H1
Gouda, M; Iijima, H; Inagaki, N; Kadowaki, T; Kaneko, G; Kondo, K; Maruyama, N; Nakanishi, N; Nishimura, K; Watanabe, Y2
Haneda, M; Hiraide, S; Ito, H; Kadowaki, T; Matsukawa, M; Sasaki, K; Ueno, M1
Cheng, F; Cheng, X; Hu, Y; Rao, J; Shen, G; Wang, X; Yang, C; Yang, S1
Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T1
Nakamura, S; Nakazato, M; Sakoda, H; Tsubouchi, C; Tsuchimochi, W; Ueno, H; Yamashita, E1
Gupta, A; Gupta, Y1
Morishita, R; Nakagami, H1
Amizuka, N; Fujie, A; Hao, W; Hasegawa, T; Katsuyama, E; Kobayashi, T; Matsumoto, M; Miyamoto, K; Miyamoto, T; Morioka, H; Morita, M; Nakamura, M; Sato, Y; Tando, T; Tashiro, S; Toyama, Y; Watanabe, R1
Ahn, CW; Cho, YW; Chung, CH; Han, KA; Hong, S; Jang, HC; Ku, BJ; Lee, CB; Lee, MK; Moon, MK; Park, CY; Park, SW; Son, HS1
Ceriello, A; De Nigris, V; La Sala, L; Prattichizzo, F; Pujadas, G; Testa, R1
Woo, V1
Okazaki, R1
Abe, Y; Anabuki, J; Fukuda-Tsuru, S; Ishii, S; Yoshida, K1
Eto, K; Hashimoto, K; Kanda, M; Sugiyama, A; Tanabe, N; Ueno, A1
Aoki, Y; Ikenaga, H; Ishii, N; Ogawa, Z; Saruta, T; Suga, T1
Collier, A; Small, M1

Reviews

2 review(s) available for thiazolidines and Hyperglycemia, Postprandial

ArticleYear
Teneligliptin : expectations for its pleiotropic action.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:3

    Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Pyrazoles; Thiazolidines

2015
[Diabetes Mellitus and bone metabolism].
    Clinical calcium, 2011, Volume: 21, Issue:5

    Topics: Bone and Bones; Diabetes Complications; Diabetes Mellitus; Diphosphonates; Fractures, Bone; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Osteoporosis; Risk; Thiazolidines

2011

Trials

3 trial(s) available for thiazolidines and Hyperglycemia, Postprandial

ArticleYear
Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
    Journal of diabetes investigation, 2021, Volume: 12, Issue:8

    Topics: Adult; Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Prospective Studies; Pyrazoles; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines

2021
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.
    Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:2

    Topics: Aged; Canagliflozin; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Exercise; Female; Humans; Hyperglycemia; Hypoglycemia; Japan; Male; Membrane Transport Modulators; Middle Aged; Pyrazoles; Sodium-Glucose Transporter 2; Thiazolidines

2018
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial.
    Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:5

    Topics: Administration, Oral; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exercise; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Incidence; Insulin Resistance; Patient Compliance; Pyrazoles; Republic of Korea; Thiazolidines; Time Factors

2016

Other Studies

13 other study(ies) available for thiazolidines and Hyperglycemia, Postprandial

ArticleYear
Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
    Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:1

    Topics: Aged; Anti-Obesity Agents; Body Mass Index; Canagliflozin; Cohort Studies; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Therapy, Combination; Exercise; Female; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Membrane Transport Modulators; Middle Aged; Overweight; Pyrazoles; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines

2018
Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients.
    Advances in therapy, 2018, Volume: 35, Issue:6

    Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Healthy; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Middle Aged; Pyrazoles; Thiazolidines

2018
Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2019, Volume: 25, Issue:7

    Topics: Aged; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Liver; Liver Diseases; Liver Transplantation; Lysophospholipids; Macrophages; Male; Mice; Middle Aged; Reperfusion Injury; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Streptozocin; Thiazolidines

2019
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
    Diabetes technology & therapeutics, 2014, Volume: 16, Issue:12

    Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines

2014
Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Endocrine journal, 2015, Volume: 62, Issue:1

    Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Japan; Middle Aged; Monitoring, Ambulatory; Postprandial Period; Pyrazoles; Thiazolidines

2015
Diabetic neuropathy: Part 2.
    JPMA. The Journal of the Pakistan Medical Association, 2014, Volume: 64, Issue:7

    Topics: Antidepressive Agents, Tricyclic; Diabetic Foot; Diabetic Neuropathies; Enzyme Inhibitors; Humans; Hyperglycemia; Oxidative Stress; Rhodanine; Thiazolidines

2014
Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation.
    The Journal of biological chemistry, 2015, Jul-10, Volume: 290, Issue:28

    Topics: Aldehyde Reductase; Animals; Calcitriol; Cell Dedifferentiation; Cells, Cultured; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Down-Regulation; Enzyme Inhibitors; Glucose; Hyperglycemia; In Vitro Techniques; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Models, Neurological; Rats; Rhodanine; Schwann Cells; Sciatic Nerve; Sorbitol; Thiazolidines; Vitamin D

2015
The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory.
    Endocrine, 2017, Volume: 56, Issue:3

    Topics: Antioxidants; Apoptosis; Cell Proliferation; Cells, Cultured; Dipeptidyl-Peptidase IV Inhibitors; Endoplasmic Reticulum Stress; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Oxidative Stress; Pyrazoles; Sitagliptin Phosphate; Thiazolidines

2017
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nath
    Diabetes care, 2009, Volume: 32, Issue:3

    Topics: Algorithms; Diabetes Mellitus, Type 2; Europe; Evidence-Based Medicine; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Societies, Medical; Thiazolidines; United States

2009
A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
    European journal of pharmacology, 2012, Dec-05, Volume: 696, Issue:1-3

    Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Nitriles; Pyrazines; Pyrazoles; Pyrrolidines; Rats; Rats, Wistar; Rats, Zucker; Sitagliptin Phosphate; Thiazolidines; Triazoles; Vildagliptin

2012
Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes.
    Japanese journal of pharmacology, 1997, Volume: 73, Issue:3

    Topics: Acetylcholine; Aldehyde Reductase; Analysis of Variance; Animals; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Experimental; Diuresis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperglycemia; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Receptors, Muscarinic; Rhodanine; Sciatic Nerve; Sorbitol; Thiazolidines; Tissue Preservation; Urinary Bladder

1997
Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats.
    Annals of clinical biochemistry, 2001, Volume: 38, Issue:Pt 4

    Topics: Acetylglucosaminidase; Analysis of Variance; Animals; Biomarkers; Blood Glucose; CD13 Antigens; Dipeptidyl Peptidase 4; Enzyme Inhibitors; gamma-Glutamyltransferase; Glomerular Filtration Rate; Glucose; Hyperglycemia; Infusions, Intravenous; Kidney; Male; Mannitol; Rats; Rats, Wistar; Rhodanine; Sorbitol; Thiazolidines; Time Factors

2001
The role of the polyol pathway in diabetes mellitus.
    British journal of hospital medicine, 1991, Volume: 45, Issue:1

    Topics: Aldehyde Reductase; Diabetes Complications; Diabetes Mellitus; Glycolysis; Glycosylation; Humans; Hyperglycemia; Imidazoles; Imidazolidines; Naphthalenes; Phthalazines; Rhodanine; Thiazolidines

1991